Subscribe to RoboticOncology.com RSS Feed

Prostate Cancer Diagnosis Increases in Men With Metabolic Syndrome

NEW YORK, NY--(Marketwired - Apr 17, 2014) - A new study shows men with metabolic syndrome-associated conditions are at increased risk of developing intermediate and aggressive prostate cancer. Canadian researchers found a 54 percent increase in prostate cancer diagnosis in men with three or more metabolic syndrome components.

David Samadi, MD, Chief of Robotic Surgery at Lenox Hill Hospital, also studies the impact of metabolic syndrome and obesity on the diagnosis and treatment of prostate cancer. In 2013, he published the results of a nine-year review of more than 2,600 of his own robot-assisted laparoscopic prostatectomy procedures. Men with metabolic syndrome were found to have larger prostates, higher tumor volume, higher pathologic Gleason scores, and increased surgical complexity.

While obesity is associated with a large number of health risks, researchers in the Canadian study noted that weight was not the driving prostate cancer risk factor. Prostate cancer diagnosis was slightly higher among obese men; however, true elevated risk was seen in men with three or more health conditions associated with metabolic syndrome. These men had 56 percent increased odds of developing intermediate- or high-risk prostate cancer. No single metabolic syndrome component was linked to increased risk, http://www.ncbi.nlm.nih.gov/pubmed/24568896

Metabolic syndrome is defined as a group of conditions that often begin with abdominal obesity. Other associated disease factors include diabetes, hypertension, low HDL cholesterol, and hypertriglyceridemia.

"Prevention strategies are critical for men with metabolic syndrome," said Dr. Samadi. "Weight loss and control of cardiovascular conditions is the best place to start. From there, we design tailored screening regimens. The good news is that we can treat prostate cancer in men with metabolic syndrome with robotic surgery."

Dr. Samadi's study demonstrated comparable surgical outcomes between patients with metabolic syndrome and non-obese patients.http://www.ncbi.nlm.nih.gov/pubmed/?term=samadi+metabolic+syndrome

Back to Press Releases


Bookmark Using:
Facebook Twitter LinkedIn Email Yahoo

Share on Facebook

Call to Make an Appointment With Dr. David Samadi:

1-212-365-5000

Click the contact link to learn how Dr. Samadi can help treat your prostate cancer and give you back your quality of life.

* The benefits of robotic surgery cannot be guaranteed as surgery is both patient and procedure specific. Previous surgical results do not guarantee future outcomes.




Testimonials
D. Cuddy, New York, USA

"My 30 day PSA came back as 0 which was great. I feel very fortunate to have adequate health coverage, access to a great physician like Dr. Samadi, and such a loving partner, family and friends who have supported me"

more..
S. Davis, USA

Dr. Samadi’s team from check-in to check-out was superlative.  And Dr. Samadi’s record of personally conducted robotic procedures and success rates are beyond compare.

more..
J. K., New York, USA

In March of 2006 I had robotic prostate surgery and was released from the hospital in 24 hours and had the catheter removed in 5 days. My PSA values have been below the detectable range for the entire year. At your hands it is the most painless and least invasive operation that a man can ever have.

more..
Jeannette B., Netherlands (en)

In 2008 my husband was diagnosed with Prostate cancer with a PSA of 31.8 and a Gleason Score of 9. When we first got the news we immediately began to research different doctors and new techniques in our home country of the Netherlands and throughout Europe.

more..